{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:03Z","timestamp":1787257443855,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao Municipality","doi-asserted-by":"publisher","award":["25-1-1-224-zyyd-jch"],"award-info":[{"award-number":["25-1-1-224-zyyd-jch"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No.ZR2020QH257"],"award-info":[{"award-number":["No.ZR2020QH257"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH257"],"award-info":[{"award-number":["ZR2020QH257"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303815"],"award-info":[{"award-number":["82303815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbc.2026.113242","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:39:18Z","timestamp":1781019558000},"page":"113242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FTO promotes cancer progression by regulating VGLL4 m6A levels to activate STAT3 signaling in triple-negative breast cancer"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-6016","authenticated-orcid":false,"given":"Hongming","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohe","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113242_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.113242_bib2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.jbc.2026.113242_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jbc.2026.113242_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/kfab021","article-title":"Emerging roles of N6-Methyladenosine (m6A) epitranscriptomics in toxicology","volume":"181","author":"Malovic","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jbc.2026.113242_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113242_bib6","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1093\/nar\/gku1116","article-title":"Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA","volume":"42","author":"Theler","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113242_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113242_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.113242_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in Cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.113242_bib10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.113242_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tig.2010.02.006","article-title":"The genetics of obesity: FTO leads the way","volume":"26","author":"Fawcett","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.jbc.2026.113242_bib12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","article-title":"FTO in cancer: functions, molecular mechanisms, and therapeutic implications","volume":"8","author":"Li","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jbc.2026.113242_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fendo.2018.00396","article-title":"Critical enzymatic functions of FTO in obesity and cancer","volume":"9","author":"Deng","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2026.113242_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.omto.2021.04.011","article-title":"m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer","volume":"21","author":"Wang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.jbc.2026.113242_bib15","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acs.jmedchem.4c02076","article-title":"Discovery of novel RNA demethylase FTO inhibitors featuring an acylhydrazone scaffold with potent antileukemia activity","volume":"68","author":"Liang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113242_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1568009620666200506110850","article-title":"Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer","volume":"20","author":"Kumari","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jbc.2026.113242_bib17","first-page":"1","article-title":"VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer","volume":"51","author":"Song","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jbc.2026.113242_bib18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbc.2026.113242_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41598-021-04316-2","article-title":"Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer","volume":"12","author":"Hsu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113242_bib20","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.3390\/ijms23073800","article-title":"FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms","volume":"23","author":"Azzam","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113242_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute Myeloid leukemia as a N(6)-Methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.113242_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cac2.12075","article-title":"The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer","volume":"40","author":"Xu","year":"2020","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.jbc.2026.113242_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41416-021-01581-w","article-title":"Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer","volume":"126","author":"Shimura","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.113242_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/cr.2014.10","article-title":"VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex","volume":"24","author":"Zhang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.113242_bib25","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-020-19141-w","article-title":"Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers","volume":"11","author":"Bradley","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113242_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jbc.2026.113242_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113242_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216764","article-title":"K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.113242_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.151901","article-title":"Histological subtype is associated with PD-L1 expression and CD8+ T-cell infiltrates in triple-negative breast carcinoma","volume":"57","author":"Salisbury","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.jbc.2026.113242_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10238-025-01872-z","article-title":"FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE","volume":"25","author":"Zhang","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jbc.2026.113242_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","article-title":"RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3","volume":"18","author":"Niu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.113242_bib32","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/febs.70033","article-title":"The m6A demethylase FTO promotes C\/EBPbeta-LIP translation to perform oncogenic functions in breast cancer cells","volume":"292","author":"Zuidhof","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2026.113242_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3724\/abbs.2023267","article-title":"Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m (6)A-dependent miR-17-5p maturation-induced ZBTB4 depletion","volume":"56","author":"Ni","year":"2024","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"10.1016\/j.jbc.2026.113242_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-025-03282-1","article-title":"Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m(6)A\/ANGPTL4\/integrin axis in triple-negative breast cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:37:36Z","timestamp":1787254656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826021149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0021925826021149"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113242","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTO promotes cancer progression by regulating VGLL4 m6A levels to activate STAT3 signaling in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113242"}}